EUVIMEDEUVIMED entdecken
Crossref

Pathology features of recurrent meningioma

V V Ushanov iD, Yu M Zabrodskaya iD, A Yu Ulitin iD, D A Sitovskaya iD, A S Sharova iD, A A Paltsev iD, A V Vasilenko iD, K K Kukanov iD

Russian Journal of Archive of Pathology · 2025

DOI: 10.17116/patol20258705128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Russian Journal of Archive of Pathology, 2025. Verfasst von V V Ushanov und 7 weiteren Autor:innen. Beteiligte Einrichtung: Almazov National Medical Research Center, St. Petersburg, Russia. Hauptthemen laut MEDLINE: Meningioma, Meningeal Neoplasms, Neoplasm Recurrence, Local, Ki-67 Antigen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the main prognostic factors for meningioma recurrence is histological diagnosis with an assessment of tumor grade. Despite this, there are no clear microscopic criteria for recurrence prognosis in benign forms, and there is no common understanding of meningioma recurrence and continued growth clinical management.

Objective

To evaluate neuroimaging, microscopic features and proliferative activity in meningioma recurrence and continued growth. Material and methods. Histological and immunohistochemical studies of tumor biopsies were performed in 16 patients with tumor progression who underwent surgery for recurrence and continued growth of intracranial meningiomas; the comparison group included 10 patients with newly diagnosed intracranial meningioma. All patients were performed pathomorphological and radiological examination assessment.

Results

The average tumor volume in the meningioma progression group was 48.88±14.32 cm3; the average tumor volume was higher in the primary surgical treatment group — 51.51±14.48 cm3. Recurrent tumors were characterized by more pronounced cellular and tissue atypia, patterns of infiltrative growth with the involvement of large vessels. The meningioma proliferative activity, assessed by Ki-67(max) expression, was higher in the group with meningioma progression and amounted to 9.71±2.5%. Significant differences in the Ki-67 expression were noted by tumor localization, grade, and brain invasion (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeningiomaMeningeal NeoplasmsNeoplasm Recurrence, LocalKi-67 AntigenBiomarkers, TumorHumansTumor BurdenNeoplasm Grading

Stichwörter der Autor:innen

meningiomaneurosurgerypathomorphologyrecurrencetumor progression

Substanzen

Ki-67 AntigenBiomarkers, Tumor

Autor:innen und Institutionen

  • Almazov National Medical Research Center, St. Petersburg, Russia.
  • I.I. Mechnikov North-Western State Medical University, St. Petersburg, Russia.
  • St. Petersburg State Pediatric Medical University, St. Petersburg, Russia.
  • City Mariinsky Hospital, St. Petersburg, Russia.

ORCID-Profile: V V Ushanov, Yu M Zabrodskaya, A Yu Ulitin, D A Sitovskaya, A S Sharova, A A Paltsev, A V Vasilenko, K K Kukanov

Zitieren

APA

Ushanov, V. V., Zabrodskaya, Y. M., Ulitin, A. Y., Sitovskaya, D. A., Sharova, A. S., Paltsev, A. A., Vasilenko, A. V., & Kukanov, K. K. (2025). Pathology features of recurrent meningioma. Russian Journal of Archive of Pathology. https://doi.org/10.17116/patol20258705128

Vancouver

Ushanov VV, Zabrodskaya YM, Ulitin AY, Sitovskaya DA, Sharova AS, Paltsev AA, et al. Pathology features of recurrent meningioma. Russian Journal of Archive of Pathology. 2025. doi:10.17116/patol20258705128

BibTeX
@article{Ushanov2025,
  author = {Ushanov, V V and Zabrodskaya, Yu M and Ulitin, A Yu and Sitovskaya, D A and Sharova, A S and Paltsev, A A and Vasilenko, A V and Kukanov, K K},
  title = {Pathology features of recurrent meningioma},
  journal = {Russian Journal of Archive of Pathology},
  year = {2025},
  doi = {10.17116/patol20258705128}
}
Kostenlos starten →